GZ-793A

Overview

GZ-793A is an orally active and selective vesicular monoamine transporter-2 (VMAT2) inhibitor, with an K i of 0.029 µM. GZ-793A inhibits the neurochemical effects of methamphetamine (METH)-induced dopamine release. GZ-793A can be used for research of METH addiction.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Monoamine Transporter

Product Information

• Catalog No.: HY-117883
• CAS No.: 1356447-90-9
• Molecular Formula: C26H38ClNO4
• Molecular Weight: 464.04
• Purity: 99.50%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source